Neurologic complications are being recognized as important outcomes of coronavirus disease 2019 (COVID-19). Pathogenesis is varied and incompletely understood, and may include neuroinvasion, indirect post-infectious neuroinflammation, and cerebrovascular pathologies. We present a case of COVID-19-related encephalomyeloradiculitis with clinical and magnetic resonance imaging characteristics of neuromyelitis optica spectrum disorders that was associated with anti-aquaporin-4 antibodies. Our case suggests post-infectious autoimmunity as a mechanism in at least a subset of patients with COVID-19-related neurologic disease.
MaoLJinHWangM, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol2020; 77(6): 1–9.
2.
NatoliSOliveiraVCalabresiP, et al. Does SARS-CoV-2 invade the brain? Translational lessons from animal models. Eur J Neurol. Epub ahead of print 25 April 2020. DOI: 10.1111/ene.14277.
3.
HindmarchCCTFergusonAV. Physiological roles for the subfornical organ: A dynamic transcriptome shaped by autonomic state. J Physiol2016; 594(6): 1581–1589.
4.
BorisowNMoriMKuwabaraS, et al. Diagnosis and treatment of NMO spectrum disorder and MOG-encephalomyelitis. Front Neurol2018; 9: 888.
5.
AsgariNFlanaganEPFujiharaK, et al. Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm2017; 4(4): e343.
6.
MatsushitaTIsobeNKawajiriM, et al. CSF angiotensin II and angiotensin-converting enzyme levels in anti-aquaporin-4 autoimmunity. J Neurol Sci2010; 295(1–2): 415–414.
7.
AssisADMascarenhasFNAPAraújoFAS, et al. Angiotensin-(1-7) receptor mas antagonist (A779) influenced gliosis and reduced synaptic density in the spinal cord after peripheral axotomy. Peptides2020; 129: 170329.
8.
PanHL.Brain angiotensin II and synaptic transmission. Neuroscientist2004; 10(5): 422–431.
9.
KogaMTakahashiTKawaiM, et al. A serological analysis of viral and bacterial infections associated with neuromyelitis optica. J Neurol Sci2011; 300(1–2): 19–22.
10.
AlbertiPBerettaSPiattiM, et al. Guillain-Barré syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm2020; 7(4): e741.
